Clinical Trial Update: A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection [Phase 1]

View source ↗

Summary

Phase I study to assess the safety, tolerability, and pharmacokinetics of AAPB for Injection in Acute Ischemic Stroke; the trial has not yet begun recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• AAPB for Injection (AAPB)

Snippet

Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd | Conditions: Acute Ischemic Stroke (AIS) | Phase 1 | Status: NOT_YET_RECRUITING